Malignant peripheral nerve sheath tumor with neurofibromatosis type 1: A 2-case report and review of the literature

Journal of the Medical Association of Thailand

Volumn 84, Issue 2, 2001, Pages 285-293

  Asavamongkolkul, Apichat ^a   Jiranantakan, Thanjira ^b   Waikakul, Saranatra ^a   Phompitaksa, Kullanuch ^a   Muangsomboon, Sorranart ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Malignant Peripheral Nerve Sheath Tumor; Neurofibromatosis Type 1

Indexed keywords

ADULT; ARTICLE; CASE REPORT; FATALITY; FEMALE; HUMAN; NEUROFIBROMATOSIS; PATHOLOGY; PERIPHERAL NERVE TUMOR; TUMOR RECURRENCE;

ADULT; FATAL OUTCOME; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEUROFIBROMATOSIS 1; PERIPHERAL NERVOUS SYSTEM NEOPLASMS;

EID: 0035259298     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. rd ed. St. Louis: C. V. Mosby, 1995: 889-928.
2. Ducatman BS, Scheithauer BW, Piepgras DG, et al. Malignant peripheral nerve sheath tumors: a clinicopathologic study of 120 cases. Cancer 1986; 57: 2006-21.
3. Bees NR, Ng CS, Dicks-Mireaux C, et al. Gastric malignant schwannoma in a child. Br J Radiol 1997; 70: 952-5.
4. Hruban RH, Shiu MH, Senie RT, et al. Malignant peripheral nerve sheath tumors of the buttock and lower extremity: a study of 43 cases. Cancer 1990; 66: 1253-65.
5. Kunisada T, Kawai A, Ozaki T, et al. A clinical analysis of malignant schwannoma. Acta Med Okayama 1997; 51: 87-92.
6. Sordillo PP, Helson L, Hajdu SI, et al. Malignant schwannoma- clinical characteristics, survival, and response to therapy. Cancer 1981; 47: 2503-9.
7. NIH Consensus Development Conference Statement: Neurofibromatosis. Neurofibromatosis 1988; 1: 172-8.
8. Kourea HP, Bilsky MH, Leung DHY, et al. Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors: a clinicopathologic study of 25 patients and 26 tumors. Cancer 1998; 82: 2191-203.
9. Crawford AH, Schorry EK. Neurofibromatosis in children: the role of the orthopaedist. J Am Acad Orthop Surg 1999; 7: 217-30.
10. Feldkamp MM, Nelson L, Provias JP, et al. Acute presentation of a neurogenic sarcoma in a patient with neurofibromatosis type 1: a pathological and molecular explanation. J Neurosurg 1996; 84: 867-73.
11. Supiyaphun P, Snidvongs K, Shuangshoti S, et al. Malignant transformation in a benign encapsulated schwannoma of retropharygeal space: a case report. J Med Assoc Thai 1997; 80: 540-6.
12. D'Agostino AN, Soule EH, Miller RH. Sarcomas of the peripheral nerves and somatic soft tissues associated with multiple neurofibromatosis (von Recklinghausen's disease). Cancer 1963; 16: 1015-27.
13. Hailing KC, Scheithauer BW, Hailing AC, et al. p 53 expression in neurofibroma and malignant peripheral nerve sheath tumor: an immunohistochemical study of sporadic and NF-1 associated tumors. Anat Pathol 1996; 106: 282-8.
14. Wong WW, Hirose T, Scheithauer BW, et al. Malignant peripheral nerve sheath tumor, analysis of treatment outcome. Int J Radiat Oncol Biol Phys 1998; 42: 351-60.
15. Wanebo JE, Malik JM, VandenBerg SR, et al. Malignant peripheral nerve sheath tumors: a clinicopathologic study of 28 cases. Cancer 1993; 71: 1247-53.
16. D'Agostino AN, Soule EH, Miller RH. Primary malignant neoplasms of nerves (malignant neurilemomas) in patients without manifestations of multiple neurofibromatosis (von Recklinghausen's disease). Cancer 1963; 16: 1003-14.
17. White HR. Survival in malignant schwannoma: an 18 year study. Cancer 1971; 27: 720-9.
18. Brown RW, Tornos C, Evans HL. Angiosarcoma arising from malignant schwannoma in a'patient with neurofibromatosis. Cancer 1992; 70: 1141-4.
19. Ducatman BS, Scheithauer BW. Malignant peripheral nerve sheath tumors with divergent differentiation. Cancer 1984; 54: 1049-57.
20. Rao UNM, Surti U, Hoffner L, et al. Cytogenetic and histologic correlation of peripheral nerve sheath tumors of soft tissue. Can Genet Cytogenet 1996; 88: 17-25.
21. Menon AC, Anderson KM, Riccardi VM, et al. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Nat Acad Sci 1990; 87: 5435-9.
22. Levine E, Huntrakoon M, Wetzel LH. Malignant nerve sheath neoplasms in neurofibromatosis: Distinction from benign tumors by using imaging techniques. AJR 1987; 149: 1059-64.
23. Reynolds JE, Fletcher JA, Lytle CH, et al. Molecular characterization of a. 17q11.2 translocation in a malignant schwannoma cell line. Hum Genet 1992; 90: 450-6.
24. Moon WK, Im JG, Han MC. Malignant schwannomas of the thorax: CT findings. J Comput Assist Tomogr 1993; 17: 274-6.
25. Malsunou H, Shimoda T, Kakimoto S, et al. Histopathologic and immunohistochemical study of malignant tumors of peripheral nerve sheath (malignant schwannoma). Cancer 1985; 56: 2269-79.
26. Herrera GA, de Moraes HP. Neurogenic sarcomas in patients with neurofibromatosis (von Recklinghausen's disease): light, electron microscopy and immunohistochemistry study. Virchows Arch (Pathol Anat) 1984; 403: 361-75.
27. Wick MR, Swanson PE, Scheithauer BW, et al. Malignant peripheral nerve' sheath tumor: an immunohistochemical study of 62 cases. New Eng J Med 1986; 305: 1617-27.
28. Wong SY, Teh M, Tan YO, et al. Malignant glandular triton tumor. Cancer 1991; 61: 1076-83.
29. Weiss SW, Langloss JM, Enzinger FM. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant schwann cell tumors. Lab Invest 1983; 49: 299-308.